Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects
Wadih Jean Naja1,2, Michaelangelo Pietro Aoun3,4
1Department of Psychiatry, Lebanese University, Beirut, Lebanon. wjnaja@gmail.com.
Purpose Of Review:
This review aims to evaluate the most recent literature examining the oxytocin (OXT) system's role in human anxiety by surveying various fields of preclinical and clinical research supporting this role, and queries whether the OXT system might be a target for novel anxiolytics.
Recent Findings:
Evidence from the diverse body of literature presented here, from translational research, genetic and neuroimaging studies, to clinical trials of intranasal (IN) OXT reveals a positive association. In addition, some moderators (e.g., sex, specificities to cues) of OXT's anxiolytic effects can have an important influence on its outcomes, awaiting further research. Evidence for the role of OXT in regulating anxiety is undeniable. We expect that the diverse particularities of the OXT system will help broaden our understanding of anxiety and stress-related disorders. We conclude that OXT promises an enticing treatment option for human anxiety disorders especially those associated with socio-emotional dysfunctions.
Insights
The oxytocin (OXT) system plays a significant role in human anxiety regulation. Research indicates OXT is a promising target for developing new anxiety treatments, particularly for socio-emotional dysfunctions.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- The oxytocin (OXT) system is increasingly recognized for its influence on social behavior and emotional regulation.
- Understanding OXT's role in anxiety is crucial for developing targeted therapeutic interventions.
Purpose of the Study:
- To review recent literature on the oxytocin system's involvement in human anxiety.
- To assess the potential of the OXT system as a target for novel anxiolytic drugs.
Main Methods:
- Comprehensive survey of preclinical and clinical research.
- Analysis of translational studies, genetic research, neuroimaging, and clinical trials.
- Evaluation of intranasal (IN) oxytocin studies.
Main Results:
- Consistent evidence supports a positive association between the OXT system and anxiety regulation.
- Oxytocin demonstrates anxiolytic effects, though influenced by factors like sex and cue specificity.
- The OXT system is undeniably involved in modulating anxiety responses.
Conclusions:
- The oxytocin system offers valuable insights into anxiety and stress-related disorders.
- Oxytocin presents a promising therapeutic avenue for human anxiety disorders, especially those with socio-emotional deficits.
Related Concept Videos
Neurotransmitters
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications
Anxiolytic Drugs: Benzodiazepines and Buspirone


